Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 24393295)

1.

New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.

Shirabe K, Toshima T, Kimura K, Yamashita Y, Ikeda T, Ikegami T, Yoshizumi T, Abe K, Aishima S, Maehara Y.

Liver Int. 2014 Jul;34(6):937-41. doi: 10.1111/liv.12459. Epub 2014 Jan 24.

PMID:
24393295
2.
3.

Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.

Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.

Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.

PMID:
19669841
4.

Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.

Hakamada K, Kimura N, Miura T, Morohashi H, Ishido K, Nara M, Toyoki Y, Narumi S, Sasaki M.

World J Gastroenterol. 2008 Mar 7;14(9):1370-7.

5.

Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?

Cheung TT, Chan SC, Ho CL, Chok KS, Chan AC, Sharr WW, Ng KK, Poon RT, Lo CM, Fan ST.

Liver Transpl. 2011 Oct;17(10):1218-25. doi: 10.1002/lt.22362.

6.

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma.

Wang CS, Lin CL, Lee HC, Chen KY, Chiang MF, Chen HS, Lin TJ, Liao LY.

World J Gastroenterol. 2005 Oct 21;11(39):6115-9.

7.

New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.

Iguchi T, Shirabe K, Aishima S, Wang H, Fujita N, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Oda Y, Maehara Y.

Transplantation. 2015 Jun;99(6):1236-42. doi: 10.1097/TP.0000000000000489.

PMID:
25427164
8.

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.

Lee JW, Paeng JC, Kang KW, Kwon HW, Suh KS, Chung JK, Lee MC, Lee DS.

J Nucl Med. 2009 May;50(5):682-7. doi: 10.2967/jnumed.108.060574. Epub 2009 Apr 16.

9.

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.

Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.

Am J Gastroenterol. 2006 Sep;101(9):2038-43. Epub 2006 Jul 18.

PMID:
16848811
10.

Tumor-to-muscle ratio of 8F-FDG PET for predicting histologic features and recurrence of HCC.

Baek YH, Lee SW, Jeong YJ, Jeong JS, Roh YH, Han SY.

Hepatogastroenterology. 2015 Mar-Apr;62(138):383-8.

PMID:
25916068
11.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
12.

Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.

Cucchetti A, Piscaglia F, Grigioni AD, Ravaioli M, Cescon M, Zanello M, Grazi GL, Golfieri R, Grigioni WF, Pinna AD.

J Hepatol. 2010 Jun;52(6):880-8. doi: 10.1016/j.jhep.2009.12.037. Epub 2010 Mar 24.

PMID:
20409605
13.

Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma.

Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, Uemoto S.

Am J Transplant. 2009 Oct;9(10):2362-71. doi: 10.1111/j.1600-6143.2009.02783.x. Epub 2009 Jul 29.

14.

Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.

Eguchi S, Takatsuki M, Hidaka M, Soyama A, Tomonaga T, Muraoka I, Kanematsu T.

World J Surg. 2010 May;34(5):1034-8. doi: 10.1007/s00268-010-0424-5.

PMID:
20127241
15.
16.

Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.

Song P, Feng X, Inagaki Y, Song T, Zhang K, Wang Z, Zheng S, Ma K, Li Q, Kong D, Wu Q, Zhang T, Zhao X, Hasegawa K, Sugawara Y, Kokudo N, Tang W; Japan-China Joint Team for Medical Research and Cooperation on HCC.

Biosci Trends. 2014 Oct;8(5):266-73.

17.

Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.

Zhao WC, Fan LF, Yang N, Zhang HB, Chen BD, Yang GS.

Eur J Surg Oncol. 2013 Aug;39(8):858-64. doi: 10.1016/j.ejso.2013.04.003. Epub 2013 May 11.

PMID:
23669199
18.

Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.

Song MJ, Bae SH, Yoo IeR, Park CH, Jang JW, Chun HJ, Choi BG, Lee HG, Choi JY, Yoon SK.

World J Gastroenterol. 2012 Jul 7;18(25):3215-22. doi: 10.3748/wjg.v18.i25.3215.

19.

Inclusion of tumor markers improves the correlation of the Milan criteria with vascular invasion and tumor cell differentiation in patients with hepatocellular carcinoma undergoing liver resection (#JGSU-D-07-00462).

Hasegawa K, Imamura H, Ijichi M, Matsuyama Y, Sano K, Sugawara Y, Kokudo N, Makuuchi M.

J Gastrointest Surg. 2008 May;12(5):858-66. doi: 10.1007/s11605-007-0464-9. Epub 2008 Jan 18.

PMID:
18202893
20.

Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.

Tameda M, Shiraki K, Sugimoto K, Ogura S, Inagaki Y, Yamamoto N, Ikejiri M, Takei Y, Ito M, Nobori T.

Cancer Sci. 2013 Jun;104(6):725-31. doi: 10.1111/cas.12149. Epub 2013 Apr 21.

PMID:
23480217
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk